Cancer centers say a shortage of chemotherapy in the United States is leading to treatment complications

Cancer centers say a shortage of chemotherapy in the United States is leading to treatment complications

A growing shortage of common cancer treatments is forcing doctors to switch medications and delay some treatments, leading US cancer centers say. The National Comprehensive Cancer Network said Wednesday that nearly every center it surveyed late last month was dealing with deficiencies in carboplatin and cisplatin, a pair of drugs used to treat a range … Read more

US doctors forced to ration as cancer drug shortages hit nationwide

Toni Dezomits during chemotherapy

Toni Dezomits had to change her ovarian cancer treatment plan due to a shortage of chemotherapy drugs Toni Dezomits, a 55-year-old retired law enforcement officer, is battling a recurrence of her stage 4 ovarian cancer. She had already undergone several rounds of chemotherapy when her doctor told her he had more bad news. Just a … Read more

Cancer patients are facing widespread shortages of chemotherapy drugs

Cancer patients are facing widespread shortages of chemotherapy drugs

Comment on this storyComment Cancer patients and their doctors are grappling with a record shortage of effective chemotherapy, putting their treatments and their lives at risk. Most are cheap generic drugs that have been used in cancer medicine for decades, says Satyajit Kosuri, clinical director of the stem cell transplant and cell therapy program at … Read more

‘Groundbreaking’ lung cancer drug cuts risk of death in half, says ‘exciting’ study.

One study found that a lung cancer drug halves the risk of death

ALUNGcancerdrug available on the NHS halves the risk of death, according to a study. Scientists say exciting study results show osimertinib will increase survival of thousands of British patients. 2 One study found that a lung cancer drug halves the risk of deathCredit: Getty 2 Osimertinib, sold under the name Tagrisso, is already available on … Read more

AstraZeneca’s new UK lung cancer drug hailed as a ‘game changer’

A British drug

AstraZeneca’s new UK lung cancer drug is hailed as a ‘game changer’ that can HALF the risk of death By Kate Pickles Updated: 5:43 PM EDT, June 4, 2023 Research has shown that a ‘breakthrough’ British drug can halve the risk of dying from lung cancer. The groundbreaking study found that patients who received osimertinib … Read more

Radiation can be safely omitted in selected patients with locally advanced rectal cancer

Be allowed

By the staff of ASCO Post Posted: 6/4/2023 11:46:00 AM Last update: 6/4/2023 10:53:02 Locally advanced rectal cancer patients with chemotherapy-responsive tumors can safely forego radiation therapy before surgery, based on results from the PROSPECT trial. These data were presented by Deborah Schrag, MD, FASCO, MPHat the ASCO Annual Meeting 2023 (Abstract LBA2) and contextually … Read more

Shortages of cancer drugs in the United States are forcing doctors to ration life-saving treatments

Shortages of cancer drugs in the United States are forcing doctors to ration life-saving treatments

A critical shortage of cancer therapies is forcing thousands of patients to lose life-saving treatments, several major health organizations have warned. There are 14 cancer drugs listed in shortage by US regulators, including the generic chemotherapy drugs cisplatin and carboplatin, which are first-line treatments for many common types of cancer. Julie Gralow, chief medical officer … Read more

“Huge breakthrough” in advanced ovarian cancer

"Huge breakthrough" in advanced ovarian cancer

UPDATED June 4, 2023 // Editor’s note: This story has been updated with additional comments from Dr. Christina Fotopoulou. CHICAGO New results in the treatment of advanced ovarian cancer were welcomed by an expert not involved in the study, even though the study showed an improvement in progression-free survival (PFS) and not yet in overall … Read more

FDA approves Olaparib Plus Abiraterone and Prednisone or Prednisolone for BRCA-mutated metastatic castration-resistant prostate cancer

Be allowed

By the staff of ASCO Post Posted: 2/6/2023 12:43:00 Last update: 6/2/2023 12:38:22 On May 31, the U.S. Food and Drug Administration (FDA) approved olaparib (Lynparza) in combination with abiraterone and prednisone (or prednisolone) for adult patients with suspected or deleterious disease BRCA extensionmutated metastatic castration-resistant prostate cancer, as determined by an accompanying FDA-approved diagnostic … Read more

Shortages of cancer drugs are forcing doctors to decide which patients to receive treatment

Shortages of cancer drugs are forcing doctors to decide which patients to receive treatment

Just six weeks ago, Greg DeStefano started a new combination of chemotherapy. The 50-year-old, from Northbrook, Illinois, had recently been diagnosed with his fourth round of cancer and doctors hoped the drug would cure the tumors growing in his neck. DeStefano was responding well, but then, in late May, he got a call from his … Read more